Back to search
Solid Tumors, Glioblastoma, Recurrent Malignant Gliomas
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Solid Tumors, Glioblastoma, Recurrent Malignant Gliomas trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Solid Tumors, Glioblastoma, Recurrent Malignant Gliomas trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Study in children and adolescents of 177Lu DOTATATE (Lutathera®) combined with the PARP inhibitor olaparib for treatment of recurrent or relapsed solid tumours…
This study will test an investigational drug called AZD1390 in combination with radiation therapy for the treatment of brain tumors. This is the first time AZD1…
This phase I trial studies the side effects and best dose of raptor/rictor-mammalian target of rapamycin (mTOR) (TORC1/2) inhibitor MLN0128 when given in combin…
This phase II trial studies how well olaparib works in treating patients with glioma, cholangiocarcinoma, or solid tumors with IDH1 or IDH2 mutations that has s…